Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Corteva delivered a strong result and managed an all-around beat in the last quarter.</li><li>The company achieved strong organic sales and earnings growth, surpassing the EBITDA margin threshold for the first time.</li><li>The company's leadership team anticipates stabilizing global supplies with two consecutive normal crop years amid tight inventories and above-average crop prices.</li></ul>

Corteva delivered a strong result and managed an all-around beat in the last quarter.The company achieved strong organic sales and earnings growth, surpassing the EBITDA margin threshold for the first time.The company's leadership team anticipates stabilizing global supplies with two consecutive normal crop years amid tight inventories and above-average crop prices.

Corteva Inc.: Remarkable Strides in Biofuels and Biologicals & Other Drivers

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/syngenta-ag-84b1a20a-a381-401b-aa06-25b303fce01e" target="_blank" data-smartkarma-citation="entities:25035:1" rel="noopener">Syngenta AG (SYNN SW)</a>, a world-class agribusiness, is seeking to raise US$9.5bn in Shanghai’s STAR market at a valuation of US$50bn. The Shanghai bourse will review the filing on 29-March.</li>
<li>The business is in rude health with accelerating growth, market share gains, solid margins and cash generation. The IPO proceeds will help reduce leverage. </li>
<li>A US$50 billion valuation is justifiable and implies a modest discount to peer multiples (including an AH premium). The IPO is worth a look.</li>
</ul>



Syngenta AG (SYNN SW), a world-class agribusiness, is seeking to raise US$9.5bn in Shanghai’s STAR market at a valuation of US$50bn. The Shanghai bourse will review the filing on 29-March.
The business is in rude health with accelerating growth, market share gains, solid margins and cash generation. The IPO proceeds will help reduce leverage. 
A US$50 billion valuation is justifiable and implies a modest discount to peer multiples (including an AH premium). The IPO is worth a look.


<ul><li>Corteva had a strong fourth quarter and managed to deliver an all-around beat.</li><li>Strong organic sales led to $370 million in profitability for the quarter, an increase in the margin of more than 200 basis points.</li><li>Strong demand for new products was the primary factor in the 9% annual increase in crop protection volume.</li></ul>

Corteva had a strong fourth quarter and managed to deliver an all-around beat.Strong organic sales led to $370 million in profitability for the quarter, an increase in the margin of more than 200 basis points.Strong demand for new products was the primary factor in the 9% annual increase in crop protection volume.

Corteva Inc.: Launch Of Vorceed Enlist Corn Products & Other Drivers

<ul><li>Corteva has had an excellent start to the fiscal year and delivered an all-around beat as sales and operational EBITDA increased by double digits due to strong client demand and consistent performance in a volatile market environment.</li><li>Crop protection saw first-half new product sales top $1 billion, up more than 60% from the same period last year.</li><li>Enlist herbicides, whose sales have more than doubled since last year, were the industry leader in this.</li></ul>

Corteva has had an excellent start to the fiscal year and delivered an all-around beat as sales and operational EBITDA increased by double digits due to strong client demand and consistent performance in a volatile market environment.Crop protection saw first-half new product sales top $1 billion, up more than 60% from the same period last year.Enlist herbicides, whose sales have more than doubled since last year, were the industry leader in this.

Corteva Inc: The Symborg Acquisition & Other Drivers

<ul>
<li>This is our first report on Corteva, a major agricultural player within the seeds and crop protection domain.</li>
<li>The company registered its Enlist Duo and Enlist One herbicides through 2029 with the U.S.</li>
<li>EPA.</li>
</ul>


This is our first report on Corteva, a major agricultural player within the seeds and crop protection domain.
The company registered its Enlist Duo and Enlist One herbicides through 2029 with the U.S.
EPA.


Corteva Inc.: Initiation of Coverage – Business Strategy

United States

Corteva, Inc. provides agricultural products. The Company offers seeds and crop protection products, as well as software solutions and digital services. Corteva serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corteva (CTVA US)

Corteva Inc.: Remarkable Strides in Biofuels and Biologicals & Other Drivers

Corteva delivered a strong result and managed an all-around beat in the last quarter. The company achieved strong organic sales and earnings...

Baptista Research

Syngenta IPO: The Investment Case

The business is in rude health with accelerating growth, market share gains, solid margins and cash generation. The IPO proceeds will help reduce...

Arun George

Corteva Inc.: Launch Of Vorceed Enlist Corn Products & Other Drivers

Corteva had a strong fourth quarter and managed to deliver an all-around beat. Strong organic sales led to $370 million in profitability for the...

Baptista Research

Corteva Inc: The Symborg Acquisition & Other Drivers

Corteva has had an excellent start to the fiscal year and delivered an all-around beat as sales and operational EBITDA increased by double digits...

Baptista Research

Corteva Inc.: Initiation of Coverage – Business Strategy

This is our first report on Corteva, a major agricultural player within the seeds and crop protection domain. The company registered its Enlist...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)